Bacteria and derived products to strengthen defences and reduce risk of illness

[EN] This invention provides a new strain of the genus Bifidobacterium and the components of the cultivation supernatants thereof in the form of diverse preparations (functional and new foods, probiotics, symbiotics, supplements, nutraceuticals and drugs) destined to improve defences and reduce the risk of illness. The mechanisms of action thereof include: (i) regulation of intestinal glycosylation promoting that of healthy individuals, (ii) modulation of interactions between epithelial cells and intestinal microbiota promoting adhesion of beneficia1 bifidobacteria and (iii) regulation of immunological responses. The products included are stable in gastrointestinal and technological conditions, ensuring their exploitation.

Saved in:
Bibliographic Details
Main Authors: Sanz Herranz, Yolanda, Palma, Giada de, Sánchez Sánchez, Esther, Medina, Marcela Susana
Format: solicitud de patente biblioteca
Language:Spanish / Castilian
Published: 2010-01-21
Subjects:Bifidobacterium,
Online Access:http://hdl.handle.net/10261/27263
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-iata-es-10261-27263
record_format koha
spelling dig-iata-es-10261-272632019-10-23T09:45:33Z Bacteria and derived products to strengthen defences and reduce risk of illness Bacterias y productos derivados para fortalecer las defensas y reducir el riesgo de enfermedad Sanz Herranz, Yolanda Palma, Giada de Sánchez Sánchez, Esther Medina, Marcela Susana Bifidobacterium [EN] This invention provides a new strain of the genus Bifidobacterium and the components of the cultivation supernatants thereof in the form of diverse preparations (functional and new foods, probiotics, symbiotics, supplements, nutraceuticals and drugs) destined to improve defences and reduce the risk of illness. The mechanisms of action thereof include: (i) regulation of intestinal glycosylation promoting that of healthy individuals, (ii) modulation of interactions between epithelial cells and intestinal microbiota promoting adhesion of beneficia1 bifidobacteria and (iii) regulation of immunological responses. The products included are stable in gastrointestinal and technological conditions, ensuring their exploitation. [ES] Esta invención aporta una nueva cepa del género Bifidobacteríum y los componentes de sus sobrenadantes de cultivo en forma de diversos preparados (alimentos funcionales y nuevos, probióticos, simbióticos, suplementos, nutracéuticos, y fármacos) destinados a mejorar las defensas y reducir el riesgo de enfermedad. Sus mecanismos de acción incluyen: (i) la regulación de la glicosilación intestinal favoreciendo la propia de individuos sanos, (ii) la modulación de las interacciones entre las células epiteliales y la microbiota intestinal, favoreciendo la adhesión de bifidobacterias beneficiosas y (iii) regulando la respuestas inmunológicas. Los productos incluidos son estables en condiciones gastrointestinales y tecnológicas, garantizando su explotación. Peer reviewed Consejo Superior de Investigaciones Científicas (España) A1 Solicitud de patentes con informe sobre el estado de la técnica 2010-08-25T11:22:31Z 2010-08-25T11:22:31Z 2010-01-21 2008-07-15 solicitud de patente WO2010007198 A1 http://hdl.handle.net/10261/27263 PCT/ES2009/070285 es open 1530505 bytes application/pdf
institution IATA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-iata-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del IATA España
language Spanish / Castilian
topic Bifidobacterium
Bifidobacterium
spellingShingle Bifidobacterium
Bifidobacterium
Sanz Herranz, Yolanda
Palma, Giada de
Sánchez Sánchez, Esther
Medina, Marcela Susana
Bacteria and derived products to strengthen defences and reduce risk of illness
description [EN] This invention provides a new strain of the genus Bifidobacterium and the components of the cultivation supernatants thereof in the form of diverse preparations (functional and new foods, probiotics, symbiotics, supplements, nutraceuticals and drugs) destined to improve defences and reduce the risk of illness. The mechanisms of action thereof include: (i) regulation of intestinal glycosylation promoting that of healthy individuals, (ii) modulation of interactions between epithelial cells and intestinal microbiota promoting adhesion of beneficia1 bifidobacteria and (iii) regulation of immunological responses. The products included are stable in gastrointestinal and technological conditions, ensuring their exploitation.
format solicitud de patente
topic_facet Bifidobacterium
author Sanz Herranz, Yolanda
Palma, Giada de
Sánchez Sánchez, Esther
Medina, Marcela Susana
author_facet Sanz Herranz, Yolanda
Palma, Giada de
Sánchez Sánchez, Esther
Medina, Marcela Susana
author_sort Sanz Herranz, Yolanda
title Bacteria and derived products to strengthen defences and reduce risk of illness
title_short Bacteria and derived products to strengthen defences and reduce risk of illness
title_full Bacteria and derived products to strengthen defences and reduce risk of illness
title_fullStr Bacteria and derived products to strengthen defences and reduce risk of illness
title_full_unstemmed Bacteria and derived products to strengthen defences and reduce risk of illness
title_sort bacteria and derived products to strengthen defences and reduce risk of illness
publishDate 2010-01-21
url http://hdl.handle.net/10261/27263
work_keys_str_mv AT sanzherranzyolanda bacteriaandderivedproductstostrengthendefencesandreduceriskofillness
AT palmagiadade bacteriaandderivedproductstostrengthendefencesandreduceriskofillness
AT sanchezsanchezesther bacteriaandderivedproductstostrengthendefencesandreduceriskofillness
AT medinamarcelasusana bacteriaandderivedproductstostrengthendefencesandreduceriskofillness
AT sanzherranzyolanda bacteriasyproductosderivadosparafortalecerlasdefensasyreducirelriesgodeenfermedad
AT palmagiadade bacteriasyproductosderivadosparafortalecerlasdefensasyreducirelriesgodeenfermedad
AT sanchezsanchezesther bacteriasyproductosderivadosparafortalecerlasdefensasyreducirelriesgodeenfermedad
AT medinamarcelasusana bacteriasyproductosderivadosparafortalecerlasdefensasyreducirelriesgodeenfermedad
_version_ 1777669958667337728